Search
Clinician Ordering Portal
Resources
Helpful resources to learn more about DecisionDx-SCC
Hear from experts and learn more about improving risk assessment in DecisionDx-SCC patients.
Individualized risk information: An introduction to DecisionDx-SCC
-
Tumor biology matters
DecisionDx-SCC is a genomic test that looks at the tumor biology of squamous cell carcinoma (SCC) of the skin to better understand the risk of cancer spreading to other parts of body
Expert opinions on the treatment and management of squamous cell carcinoma.
-
Brent Moody, MD, FACP, FAAD, Dermatologist and Mohs Surgeon, Heritage Medical Associates
Learn how Mohs Surgeon Dr. Brent Moody utilizes DecisionDx-SCC for his high-risk SCC patients to clarify their cancer management and treatment plans.
-
David Cotter, MD, PhD, Dermatologist, Las Vegas Dermatology
Learn about what Dermatologist Dr. David Cotter finds most valuable about utilizing DecisionDx-SCC to personalize care for his high-risk SCC patients.
-
Philip Andrews, NP, Dermatology, Chattanooga Skin and Cancer Clinic
Learn how Dermatology Nurse Practioner Philip Andrews utilizes DecisionDx-SCC to improve follow-up, referral and treatment recommendations for his high-risk SCC patients.
Explore on-demand content
-
AHNS DecisionDx–SCC Webinar: Identifying the Risk of Metastasis in cSCC and cSCC-HN Patients
Jason Newman, MD, FACS, Professor of Otorhinolaryngology – Head and Neck Surgery, University of Pennsylvania
CME/CE: N/A
-
Maui Derm DecisionDx-SCC Product Theater: Identifying the Risk of Metastasis in cSCC Patients with One or More Risk Factors.
Faculty: Brent Moody, MD, FACP, FAAD, Fellow, American College of Mohs Surgery
CME/CE: N/A
-
Enhanced Metastatic Risk Assessment in Cutaneous Squamous Cell Carcinoma with the 40-Gene Expression Profile Test: An Interview with the Lead Author of DecisionDx-SCC’s Validation Study
Sherrif F. Ibrahim, MD, PhD, Assistant Professor, Department of Dermatology, University of Rochester Medical Center
CME/CE: N/A
-
The DecisionDx-SCC test is a game changer”
Phil Andrews, NP/PA
